Dartmouth researchers discover gene signatures for scleroderma

July 16, 2008

Finding distinct molecular signatures offers new hope for still puzzling disorder

Hanover, NH-- Distinct genetic profiles can discern different groups of patients with scleroderma, a vexing autoimmune disease in which the body turns against itself, Dartmouth Medical School researchers report. Their discovery of distinguishing molecular subtypes within the disease offers new insight into the complexity of a poorly understood and hard to treat illness and opens a window for better diagnosis and targeted therapies.

Scleroderma is a chronic connective tissue disorder that can cause skin hardening and internal organ dysfunction and affects four times as many women as men. It captures a range of related conditions, from mild, localized to the skin, to systemic and life threatening.

Patient complications are variable and hard to predict, explains Dr. Michael Whitfield, assistant professor of genetics at DMS, who headed the research team. "We show that we can divide the patients even more finely than what is currently done clinically, and found a clear association between disease severity and gene expression. " The results were published online, July 16 in PLoS ONE, an open-access journal of the Public Library of Science.

"We show for the first time that we can classify patients with a systemic autoimmune disease into different groups by gene expression patterns alone," says Whitfield "Now that we have discovered new subsets at the molecular level, we can begin to map the genetic pathways to see if we can we use these signatures to predict who will progress to different clinical endpoints." The researchers hope to begin to understand which patients should be treated aggressively, for example, and which drugs benefit which patients.

"Scleroderma constitutes one of the most mysterious of human diseases. The studies by the Whitfield group are particularly noteworthy as they constitute the first genetic categorization of scleroderma," says Dr. William Rigby, a DMS rheumatolgist who treats scleroderma. "Since no one understands the basic processes that cause scleroderma, it has been largely categorized by the distribution of clinical findings, such as the location of skin thickening (torso relative to the hands). These studies, utilizing objective measures, establish that distinct genetic programs account for the ways this disease manifests itself and hold out the possibility for an improved ability to treat and induce remission of this potentially fatal disease," adds Rigby, who is a professor of medicine and of microbiology and immunology.

The work continues a longtime collaboration with Dr. Kari Connolly at the University of California, San Francisco, which has a large scleroderma patient population. It builds on a map of skin that Whitfield and colleagues created using gene expression -- which genes are turned on-- to delineate differences among scleroderma patients beyond obvious symptoms.

The map was based on skin samples from patients with diffuse scleroderma, the most severe form of the disease, and healthy controls. Two skin samples were taken from each patient: one from affected skin in the forearm, and another from an unaffected lower back area, which though seemingly healthy, also showed aberrant genes, demonstrating the disease was truly systemic when the biopsies were taken.

The new research is considered the largest scleroderma gene expression study to date. The investigators analyzed gene activity in 28 patients with varying types of scleroderma and six healthy control subjects, using skin biopsies from an arm and back.

Whitfield compares the molecular classification to how breast and other cancers have been characterized. "Our goal was to go into a disease of completely different etiology, but plagued by similar problems of clinical heterogeneity and to quantify disease subsets at the gene expression level."

The researchers used DNA mircoarrays to measure gene expression and computational algorithms to select subsets of genes that can classify the patients. The technology offers an objective way to survey and analyze thousands of genes at a time and look at inherent gene programs in the skin samples, which like most cells, contain all the human genetic information.

The patients split into four major groups, each with a distinct gene profile. One group with severe disease had a proliferation signature, indicating dividing cells. An inflammatory group included several forms of the disease with a signature for T cells and other characteristics of inflammation. Another signature was limited to patients with more serious vascular and less skin involvement, while a fourth, normal-like group included healthy controls as well as patients diagnosed as having the more severe diffuse disease, and limited disease. The researchers also identified a gene signature that highly correlated with increased severity of skin disease.

The results, according to Whitfield, help tie together basic and clinical science for scleroderma and could potentially be used as an outcome measure in clinical trials. Studies are in progress, he adds, to help define response signatures for specific therapies and determine which drugs will work best for different patient profiles.

Dartmouth Medical School

---

---

	The Scleroderma Book: A Guide for Patients and Families by Maureen D. Mayes M.D. (Author) The Scleroderma Book has long been considered the leading source of information for patients suffering with this disease. Now comes the Second Edition of this highly respected volume, extensively revised by Maureen Mayes, M.D., the leading authority in this field. Writing specifically for patients and their families, Dr. Mayes draws on her extensive experience treating scleroderma to provide up-to-date, practical information that will help patients manage their symptoms and improve their quality of life. Dr. Mayes begins with an easily accessible description of the basic facts, distinguishing between the many manifestations of the disease, ranging from localized scleroderma (small patches of hardened skin, most common in children, which tend to clear up over time) to systemic...
	The First Year: Scleroderma: An Essential Guide for the Newly Diagnosed (The First Year Series) by Karen Gottesman (Author), M.D. Daniel E. Furst M.D. (Foreword) Scleroderma—a chronic autoimmune condition that causes hardening, thickening, or tightening of the skin and attacks the heart, lungs, kidneys, and gastrointestinal tract—is extraordinarily difficult to diagnose and can take a huge toll on the psychological well-being of the individual. From the first moment of her diagnosis, author Karen Gottesman took charge and educated herself on every aspect of her condition. Now, as a "patient-expert," she guides those newly diagnosed step by step through their first year with scleroderma. She provides crucial information about the nature of the disease, treatment options, diet, exercise, social concerns, emotional issues, networking with others, and much more. The First Year™—Scleroderma is illustrated with charts and tables, and offers an...
	Scleroderma: The Proven Therapy that Can Save Your Life by Henry Scammell (Author) Scleroderma, which affects as many as 400,000 Americans, starts off like skin cancer but is far more deadly. This new edition is updated with new information about the best therapy for this disease, including the results of the landmark first, and a new, second clinical trial of the only therapy to report reversal and remission of this deadly disease.
	If You Have to Wear an Ugly Dress, Learn to Accessorize: Guidance, Inspiration, and Hope for Women with Lupus, Scleroderma, and Other Autoimmune Illnesses by Linda McNamara (Author), Karen Kemper (Author) "Lupus and scleroderma are our shadows but they do not define us. We may have to wear the ugly dresses of chronic illness but we don't have to be the ugly dresses." -- Linda and Karen If you are experiencing a long-term illness or disability, this book is for you -- as well as your family and friends. The authors share a collection of deeply personal stories and poetry to describe their journey from illness to health, well-being, and fruitful living. Their creative life management strategies provide a road map to help you: overcome overwhelming feelings of loss, grief, anger, fear, and powerlessness; navigate a healthcare system filled with individuals who can be patronizing or dismissive; field well-intentioned but hurtful remarks such as, "But you look so good!" walk the...
	Scleroderma: From Pathogenesis to Comprehensive Management by John Varga (Editor), Christopher P. Denton (Editor), Fredrick M. Wigley (Editor) This essential resource presents the most up-to-date information on scleroderma. A clear and concise synthesis of current concepts in pathogenesis and modern approaches to management, this book is comprised of the authoritative work of international experts. With an integrated multidisciplinary approach to comprehensive care, this book is easily accessible for health care professionals in many fields. It is a valuable resource for rheumatologists, pulmonologists, cardiologists, gastroenterologists, nephrologists and all those involved in the care of scleroderma patients.
	Medifocus Guidebook on: Scleroderma by Medifocus.com Inc. (Author), Elliot Jacob PhD. (Editor) The MediFocus Guidebook on Scleroderma is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Scleroderma, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Scleroderma, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts, institutions, and support organizations...
	Voices of Scleroderma, Vol. 3 by International Scleroderma Network (Author) “I highly recommend this book for patients, caregivers, and medical professionals who want quality medical information and support for scleroderma and related illnesses. “Access to high quality reliable modern information is crucial to patient well-being and outcomes. The realization that ‘you ARE NOT alone’ has therapeutic value in its own right. “The nonprofit International Scleroderma Network (ISN) and its website at www.sclero.org enjoys a well-deserved reputation for top-notch medical and support information and services from both the patient and medical organizations throughout the world. Each book in this series features enlightening articles from esteemed scleroderma researchers as well as over 100 unique patient and caregiver stories from 16 countries and in 5...
	21st Century Scleroderma Sourcebook: Clinical Data for Patients, Families, and Physicians, including Morphea and Linear, Systemic Sclerosis, Raynaud's Phenomenon, Sclerodactyly, Related Conditions by Progressive Management This comprehensive compilation provides authoritative information and practical advice from the nation's health experts about scleroderma and related conditions. Starting with the basics, and advancing to detailed patient-oriented and physician-quality information, the 21st Century Sourcebook series gives empowered patients, families, caregivers, nurses, and physicians the information they need to understand this disease. There is extensive coverage of symptoms, diagnosis, medical testing, treatment options, clinical research, and prognosis. A comprehensive list of clinical trials related to scleroderma is included. Related topics are fully covered: Raynaud's phenomenon, morphea and linear scleroderma, localized scleroderma and systemic sclerosis, CREST, and more. Derived from...
	A Journey Towards Health ... Reversing Scleroderma by Jane M. Parker (Author), Victor Dyment (Author), Elieba Levine (Editor) Answers do exist for seemingly incurable diseases. The information contained in this book applies to a diverse variety of conditions ranging from ADD, Autism, Scleroderma, and MS to psoriasis and eczema. We all have the ability to reach good health by changing to the correct materials such as dental, clothing and furniture. This book follows Jane Parker's journey from the diagnosis of systemic Scleroderma, a fatal autoimmune disease, to good health. After a year of unanswered questions, numerous doctors and alternative practitioners, she finally received a correct diagnosis of Scleroderma. In researching the disease she found there was no known way to cure it. All existing information held no hope for survival – and definitely none for a reversal, but this...
	Fiddler's Daughter: Living with Scleroderma by Clauda (Martin) Lavertu (Author), John P Lavertu (Cover Design), Edgar Lavertu (Cover Design) In this autobiography/memoir, Clauda (Martin) Lavertu describes the many challenges in her life. Being brought up with a sometimes difficult father, then in middle age being diagnosed with scleroderma, she persevered with the help of her mother and her faith. The large family was brought up with music, song, and dance, and always stayed close and supported each other. Getting to understand her father and learning to live with a disease, she always found a way to stay strong and to face the challenges head-on. In a small, French-speaking town in New Brunswick, Canada, the large family experienced many happy and fun times but also difficult times with a father who was frequently away for work or playing his fiddle. She grew up fearing her father who sometimes was difficult, but loved his...